These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35514680)

  • 1. Retracted Article: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation
    Deng D; Ye X; Wang X; He G
    RSC Adv; 2019 Jun; 9(35):20385-20394. PubMed ID: 35514680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation
    Fisher L
    RSC Adv; 2021 Apr; 11(27):16478. PubMed ID: 35481960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
    BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulating NEAT1 inhibited the viability and vasculogenic mimicry formation of sinonasal squamous cell carcinoma cells via miR-195-5p/VEGFA axis.
    Lu H; Kang F
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p.
    Hou J; Wang L; Wu Q; Zheng G; Long H; Wu H; Zhou C; Guo T; Zhong T; Wang L; Chen X; Wang T
    Stem Cell Res Ther; 2018 Apr; 9(1):109. PubMed ID: 29673400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-199a-5p aggravates primary hypertension by damaging vascular endothelial cells through inhibition of autophagy and promotion of apoptosis.
    Tian X; Yu C; Shi L; Li D; Chen X; Xia D; Zhou J; Xu W; Ma C; Gu L; An Y
    Exp Ther Med; 2018 Aug; 16(2):595-602. PubMed ID: 30116316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal MiR-199a-5p Inhibits Tumorigenesis and Angiogenesis by Targeting VEGFA in Osteosarcoma.
    Zhang L; Cao H; Gu G; Hou D; You Y; Li X; Chen Y; Jiao G
    Front Oncol; 2022; 12():884559. PubMed ID: 35651811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-17-5p promotes the endothelialization of endothelial progenitor cells to facilitate the vascular repair of aneurysm by regulating PTEN-mediated PI3K/AKT/VEGFA pathway.
    Tian Y; Li X; Bai C; Yang Z; Zhang L; Luo J
    Cell Cycle; 2020 Dec; 19(24):3608-3621. PubMed ID: 33315517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-199a-5p inhibits dermal papilla cells proliferation by regulating VEGFA expression in cashmere goat.
    Zhang T; Zheng Y; Zhang F; Wang X; Du J; Wang X
    Gene; 2024 Jan; 893():147901. PubMed ID: 37839765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase 6 negatively regulated microRNA-199a-5p induces the occurrence of preeclampsia by targeting VEGFA in vitro.
    Mei Z; Huang B; Zhang Y; Qian X; Mo Y; Deng N
    Biomed Pharmacother; 2019 Jun; 114():108805. PubMed ID: 30947018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing hsa_circ_PVT1 (circPVT1) suppresses the growth and metastasis of glioblastoma multiforme cells by up-regulation of miR-199a-5p.
    Chi G; Yang F; Xu D; Liu W
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):188-196. PubMed ID: 31865777
    [No Abstract]   [Full Text] [Related]  

  • 13. MiR-199a-5p suppresses proliferation and invasion of human laryngeal cancer cells.
    Li DJ; Wang X; Yin WH; Niu K; Zhu W; Fang N
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12200-12207. PubMed ID: 33336738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA-93-5p Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Targeting the PTEN-Mediated PI3K/Akt Signaling Pathway.
    Wu Y; Xu W; Yang Y; Zhang Z
    Ann Clin Lab Sci; 2021 May; 51(3):310-320. PubMed ID: 34162560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-448-5p/VEGFA Axis Protects Cardiomyocytes from Hypoxia Through Regulating the FAS/FAS-L Signaling Pathway.
    Tang H; Zhang S; Huang C; Li K; Zhao Q; Li X
    Int Heart J; 2021 May; 62(3):647-657. PubMed ID: 33994507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-199a-5p promotes ferroptosis-induced cardiomyocyte death responding to oxygen-glucose deprivation/reperfusion injury via inhibiting Akt/eNOS signaling pathway.
    Zhang GY; Gao Y; Guo XY; Wang GH; Guo CX
    Kaohsiung J Med Sci; 2022 Nov; 38(11):1093-1102. PubMed ID: 36254861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-199a-5p regulates β1 integrin through Ets-1 to suppress invasion in breast cancer.
    Li W; Wang H; Zhang J; Zhai L; Chen W; Zhao C
    Cancer Sci; 2016 Jul; 107(7):916-23. PubMed ID: 27094578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circVMA21 ameliorates lipopolysaccharide (LPS)-induced acute kidney injury by targeting the miR-199a-5p/NRP1 axis in sepsis.
    Li X; Li R; Gong Q; Shi D; Song L; Song Y
    Biochem Biophys Res Commun; 2021 Apr; 548():174-181. PubMed ID: 33647793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted Article: miR-199a-3p knockdown inhibits dedifferentiated liposarcoma (DDLPS) cell viability and enhances apoptosis through targeting casein kinase-1 alpha (CK1α).
    Cao Y; Zheng J; Lv C
    RSC Adv; 2019 Jul; 9(39):22755-22763. PubMed ID: 35519458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.